Abstracts by key term: supply situation
The second part of the review on the diagnosis and care of patients with metabolically associated steatohepatitis (MASH) addresses the challenges and recommendations, taking into account the current S2k guidelines. The diagnostic algorithm focuses on a screening procedure for the early detection of MASH, with primary care physicians playing a key role. Elevated liver function tests or an abnormal fatty liver index (FLI) indicate further testing and, if necessary, referral to a specialist. Early identification is essential, especially in high-risk groups such as individuals with type 2 diabetes, obesity, or metabolic syndrome, to enable preventive action. Comprehensive metabolic diagnostics are a prerequisite for preventing disease progression. However, the care situation in the diagnosis of MASH is characterized by a number of limitations, including the limited application of the screening algorithm and the challenges of making a definitive diagnosis using liver biopsy. The discrepancy between the diagnosed number of MASH cases and the presumed prevalence indicates a significant number of undiagnosed cases, which ultimately leads to therapeutic deficits.
03.06.2024
Chronic coronary heart disease (CHD) contributes significantly to mortality, morbidity and loss of quality of life in Germany. Improved therapies and secondary and tertiary drug prevention have contributed to a significant decrease in CHD-related mortality in recent years. The improved survival with CHD and the growing proportion of the older population lead to an increase in the prevalence of the disease and its complications. The present publication is intended to present the morbidity, mortality and prevalence of chronic CHD in Germany and to identify the population groups that are particularly frequently affected by the disease. In addition, aspects of the burden of disease (quality of life, premature mortality and medical costs) are taken into account. Furthermore, gaps in care and potential for optimizing secondary and tertiary prevention for patients with chronic CHD should be identified.
24.01.2013
Diabetic foot syndrome is a secondary disease of diabetes mellitus and often leads to non-traumatic amputations. These are associated with high medical costs, loss of quality of life and high mortality (Heller et al. 2004). Diabetic foot syndrome occurs with a prevalence of 6.5% among type 2 diabetes patients (Lauterbach et al. 2010). Endogenous risk factors such as B. diabetic polyneuropathy or peripheral arterial disease (PAD) have a prevalence of 30% and 25%, respectively (Lauterbach et al. 2010). Prevention of diabetic foot syndrome is therefore very important. In addition to the endogenous risk factors mentioned, exogenous factors such as: For example, inadequate footwear or poor foot care play a crucial role (Uccioli et al. 1995; Chantelau/Haage 1994; Brent et al. 2006). According to the International Consensus on the Diabetic Foot (1999), the prevalence of diabetic foot syndrome could be reduced through, among other things, regular inspections of the feet and footwear, training of patients and family members and the wearing of suitable footwear. An important and effective intervention measure is to train and instruct patients to self-inspect their feet.